FDA approves Pfizer-BioNTech COVID vaccine booster for emergency use in 16- and 17-year-olds

Pfizer and BioNTech announced Thursday that the companies' COVID-19 had received emergency use authorization from the Food and Drug Administration for individuals 16 years of age and older.